CancerDrs

Breast Cancer clinical trials in Maine

4 actively recruiting breast cancer trials at 12 sites across Maine.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Network

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medicat…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT05929768
Sites in Maine:
  • Harold Alfond Center for Cancer Care — Augusta, Maine
  • New England Cancer Specialists - Kennebunk — Kennebunk, Maine
  • Penobscot Bay Medical Center — Rockport, Maine
  • MaineHealth Cancer Care and IV Therapy - South Portland — South Portland, Maine
  • New England Cancer Specialists - Topsham — Topsham, Maine
View on ClinicalTrials.gov →
Phase 2 Recruiting Academic/Other

ATEMPT 2.0: Adjuvant T-DM1 vs TH

This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of …

Sponsor: Dana-Farber Cancer Institute
NCT ID: NCT04893109
Sites in Maine:
  • Eastern Maine Medical Center (Northern Light) — Brewer, Maine
  • New England Cancer Specialists — Scarborough, Maine
View on ClinicalTrials.gov →
Phase 2 Recruiting Academic/Other

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The nam…

Sponsor: Dana-Farber Cancer Institute
NCT ID: NCT04468061
Sites in Maine:
  • Eastern Maine Medical Center — Brewer, Maine
View on ClinicalTrials.gov →
Recruiting Academic/Other

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …

Sponsor: Wake Forest University Health Sciences
NCT ID: NCT06418204
Sites in Maine:
  • Harold Alfond Center for Cancer Care — Augusta, Maine
  • MaineHealth Waldo Hospital — Belfast, Maine
  • MaineHealth Maine Medical Center - Biddeford — Biddeford, Maine
  • MaineHealth Cancer Care and IV Therapy - Brunswick — Brunswick, Maine
  • Mid Coast Hospital — Brunswick, Maine
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-01